Everolimus
NDC 72319-003, everolimus, tablet, from i3 Pharmaceuticals, LLC.
- Product NDC
- 72319-003
- Status
- Listed
- Labeler
- i3 Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219464
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72319-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS.25 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72319-003-02 | 72319000302 | 60 TABLET in 1 CONTAINER (72319-003-02) |
| 72319-003-60 | 72319000360 | 60 BLISTER PACK in 1 CARTON (72319-003-60) / 10 TABLET in 1 BLISTER PACK (72319-003-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/be5da0fd-8fd4-4f84-a307-f270048d503c
Use it
Look up 72319-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72319-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72319-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.